Responses
Oral Presentations
Progress in biological treatment of RA
OP0101 Risk of opportunistic infections in patients with rheumatoid arthritis initiating abatacept: analysis of all available clinical trial data
Compose a Response to This Article
Other responses
No responses have been published for this article.